PUBLICATION

  1. Yuliwulandari R, Prayuni K, Razari R, Susilowati RW, Zulhamidah Y, Soedarsono, Sofro ASM, Tokunaga K. Genetic Characterization of NAT2 variants in acquired MDR-TB in Indonesia. Pharmacogenomics. 2020 (a head of print)
  2. Soedarsono, Amin M, Tokunaga K, Yuliwulandari R, Dewi DNSS, Mertaniasih NM. Association of disease severity with toll-like receptor polymorphism in MDR-TB patients. International Journal of Mycobacteriology. 2020; 9(4):380

1. R Yuliwulandari , International Journal: Genome-wide association studies of tuberculosis in Asians identify distinct at-risk locus for young tuberculosis [LINK]
2. R Yuliwulandari , International Journal: Association of HLA-A,-B, and-DRB1 with pulmonary tuberculosis in western Javanese Indonesia
3. R Yuliwulandari ,International Journal: NAT2 ultra-slow acetylator and risk of anti-tuberculosis drug-induced liver injury: a genotype-based meta-analysis
4. K Prayuni, I Razari, R Yuliwulandari , Glutathione S-transferase M1 and T1 null allele frequencies among Indonesian ethnics toward improved disease risk assessment [LINK]

  1. S Soedarsono, S Mandayani, K Prayuni, R Yuliwulandari , THE RISK FACTORS FOR DRUG INDUCED HEPATITIS IN PULMONARY TUBERCULOSIS PATIENTS IN DR. SOETOMO HOSPITAL [LINK]
  2. Suvichapanich S, Fukunaga K, Zahroh H, Mushiroda T, Mahasirimongkol S, Toyo-Oka L, Chaikledkaew U, Jittikoon J, Yuliwulandari R, Yanai H, Wattanapokayakit S, Tokunaga K. NAT2 ultra-slow acetylator and risk of anti-tuberculosis drug-induced liver injury: a genotype-based meta-analysis. Pharmacogenetics and genomics. 2018; 28(7):167-176.
  3. Manolio TA, Hutter CM, Avigan M, Cibotti R, Davis RL, Denny JC, Grenade LL, Wheatley LM, Carrington MN, Chantratita W, Chung WH, Dalton AD, Hung SL, Lee MTM, Leeder JS, Lertora JJL, Mahasirimongkol S, McLeod HL, Mockenhaupt M, Pacanowski M, Phillips EJ, Pinheiro S, Pirmohamed M, Sung C, Suwankesawong W, Trepanier L, Tumminia SJ, Veenstra D, Yuliwulandari R, Shear NH. Research directions in genetic predispositions to Stevens-Johnson syndrome/toxic epidermal necrolysis. Clinical Pharmacology & Therapeutics. 2018; 103(3): 390-394.
  1. Rika Yuliwulandari, Erna Kristin, Kinasih Prayuni, Qomariyah Sachrowardi, Franciscus D Suyatna, Sri Linuwih Menaldi, Nuanjun Wichukchinda, Surakameth Mahasirimongkol, Larisa H Cavallari , “Association of the HLA-B alleles with carbamazepine-induced Stevens–Johnson syndrome/toxic epidermal necrolysis in the Javanese and Sundanese population of Indonesia: the important role of the HLA-B75 serotype” [LINK]
  2. Yuliwulandari R, Prayuni K, Usman H, Sachrowardi Q, Tokunaga K. Differentiation of N- acetyltransferase 2 (NAT2) rapid and intermediate acetylator based on genotype and urinary assay. Australasian Medical Journal. 2017; 10(10): 879-883. 
  3. Yuliwulandari R, Diana NE, Prayuni K. The First Modular Database of Indonesian Genes- Associated Diseases Information. Journal of Theoretical and Applied Information Technology. 2017; 95(6): 1499-1058. 
  4. Susilowati RW, Prayuni K, Razari I, Bahri S, Yuliwulandari R. High Frequency of NAT2 slow acetylator alleles in the Malay population of Indonesia: an awareness to the anti-tuberculosis drug induced liver injury and cancer.  Medical Journal of Indonesia. 2017;26 (1): 7-13.